Fee Proposal for Drugs and Medical Devices
Fee Proposal for Drugs and Medical Devices Published for Consultation
By: Teri Dickinson, Manager Regulatory Affairs Group, email
On May 24th, 2018 published the revised proposal for Drugs and Medical Devices based on comments received. There were a few significant changes in cost structures which will now be phased in over 4 years and a bit of relief for disinfectants.
Submission | Current Fee | Formerly Proposed Fee | 2019/20 Proposed Fee | 2020/21 Proposed Fee | 2021/22 Proposed Fee | 2022/23 Proposed Fee |
| Administrative Submission | $324 | $1401 | $423 | $529 | $662 | $828 |
| Category IV Monograph/Labelling Standard | $1726 | $1901 | $1584 | $1584 | $1584 | $1584 |
| Full review new Disinfectant with efficacy submission | $4305 | $16,214 | $5600 | $7000 | $8750 | $10938 |
| Drug Right to Sell annual fee (Disinfectant) | $1152 | $4587 | $1259 | $1317 | $1375 | $1433 |
Fees related to food and human natural health products are not part of this proposal. Health Canada will review fees for products that will be part of the Self‐Care Framework, including human natural health products and over‐the‐counter (OTC) products.
Contact:
Dell Tech Laboratories
info@delltech.com
519-858-5021
Dell Tech has provided professional, confidential consulting services to the chemical specialty
industry in Canada, the USA, Europe, and Asia for the last 40 years.
Contact us today for more information.
www.delltech.com
Recommended Posts
English 
